ENDEFR
Home › United States › Bioverativ Therapeutics Inc.

Bioverativ Therapeutics Inc.

Domestic Business Corporation (Company) · Boston, United States · LEI 549300FG1M08D5DJ1X84
LEI lapsed

Summary

Bioverativ Therapeutics Inc. is registered in the United States. Its legal form is Domestic Business Corporation (Company). According to GLEIF, its ultimate parent is SANOFI (France), and its direct parent is Bioverativ Inc. (United States). That group has 76 subsidiaries with LEIs in 33 countries, 4 of them in the United States. The LEI was first issued on 5 Jun 2018 and the record was last updated on 4 Aug 2023. It has lapsed: renewal was due by 4 Jun 2019. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 4 Jun 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Mar 2018, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 15 Sep 2022.

Company details

Legal formDomestic Business Corporation (Company)
Register · Register website
Registration number133957867
Registration authorityCorporations Division (Secretary of the Commonwealth's Office)
JurisdictionUnited States (US-MA)
Registered addressC/O Corporation Services Company, 84 State Street, 02109 Boston, United States
Headquarters address225 Second Avenue, MA 02451 Waltham, United States
Categorycompany or other legal entity
Statusactive
LEI549300FG1M08D5DJ1X84
LEI statuslapsed
LEI first issued5 Jun 2018
LEI record last updated4 Aug 2023
Next LEI renewal4 Jun 2019
Corroboration of the LEI recordfully corroborated

Group membership

SANOFI France ultimate parent
Bioverativ Inc. United States lapsed direct parent
Bioverativ Therapeutics Inc. this entity
View the whole group: 76 subsidiaries in 33 countries

Relationship to the parent

Direct parentUltimate parent
ParentBioverativ Inc.SANOFI
Accounting period1 Apr 2017 to 31 Mar 20181 Apr 2017 to 31 Mar 2018
Evidencesupporting documentssupporting documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start4 Jun 20184 Jun 2018
Recorded at GLEIF since5 Jun 20185 Jun 2018
Last updated31 Jul 202315 Sep 2022
Record statusnot renewednot renewed

Other names

  • Syntonix Pharmaceuticals · previous name